Balyasny Asset Management’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-25,841
| Closed | -$82K | – | 2282 |
|
2022
Q3 | $82K | Buy |
+25,841
| New | +$82K | ﹤0.01% | 1932 |
|
2021
Q4 | – | Sell |
-733,180
| Closed | -$4.92M | – | 1938 |
|
2021
Q3 | $4.92M | Buy |
733,180
+472,324
| +181% | +$3.17M | 0.02% | 678 |
|
2021
Q2 | $2.07M | Buy |
260,856
+234,798
| +901% | +$1.86M | 0.01% | 882 |
|
2021
Q1 | $198K | Buy |
+26,058
| New | +$198K | ﹤0.01% | 1399 |
|
2020
Q1 | – | Sell |
-33,653
| Closed | -$287K | – | 983 |
|
2019
Q4 | $287K | Buy |
+33,653
| New | +$287K | ﹤0.01% | 952 |
|
2019
Q1 | – | Sell |
-110,000
| Closed | -$1.04M | – | 1265 |
|
2018
Q4 | $1.04M | Sell |
110,000
-437,054
| -80% | -$4.13M | 0.01% | 794 |
|
2018
Q3 | $4.38M | Buy |
547,054
+520,953
| +1,996% | +$4.17M | 0.02% | 593 |
|
2018
Q2 | $243K | Buy |
+26,101
| New | +$243K | ﹤0.01% | 1401 |
|